KYAN Therapeutics Announces Collaboration with Institute of Molecular and Cell Biology for Accelerated Drug Discovery and Development of Nucleic Acids
- Written by Reporters
SINGAPORE - Media OutReach - 19 August 2021 - KYAN Therapeutics, Inc. (KYAN), a developer of optimised therapeutics, and the Agency of Science, Technology & Research (A*STAR)'s Institute of Molecular and Cell Biology (IMCB), a premier cell and molecular biology institute, have entered into a collaboration to discover and...